Envisagenics

Our mission is to reduce the complexity of biomedical data into innovative therapeutic solutions

Founded 2014
1-15 employees
  • Biotechnology & Chemical Products
  • Headquarters address
    335 Madison Ave. New York, NY 10017

    Envisagenics, Inc. is a bioinformatics company spun out of Cold Spring Harbor Laboratory. The company’s mission is to boost the creation of new therapies for human diseases by reducing the complexity of biomedical big data into plausible solutions. Envisagenics focuses on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors and more remain to be discovered.

    Envisagenics’ breakthrough technology, SpliceCoreTM, is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data. The company will use its software to identify new splicing errors causative of the disease, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Envisagenics' in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost, and failure risk of drug development programs.

    Tech stack

    We are language agnostic, Preferred skills:, MVC, object oriented programming, rails, python, scala/java/GO, c++, NoSQL, Hadoop/Spark, Docker, Git, Rest API, AWS/Azure/GCP

    Benefits

    Compensation and retirement

    401k plan

    Health and wellness

    Insurance (Health)
    Insurance (Dental)
    Insurance (Vision)
    Insurance (Life)
    Insurance (Disability)